Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > INCY Incyte > Detailed Quotes

INCY Incyte

66.440
+0.260+0.39%
Close 09/27 16:00 ET
66.4400.0000.00%
Post Mkt Price 09/27 16:58 ET
High
67.530
Open
66.480
Turnover
121.06M
Low
65.880
Pre Close
66.180
Volume
1.82M
Market Cap
14.78B
P/E(TTM)
15.63
52wk High
84.860
Shares
222.43M
P/E(Static)
15.56
52wk Low
61.910
Float Cap
12.20B
Bid/Ask %
0.00%
Historical High
153.150
Shs Float
183.64M
Volume Ratio
1.47
Historical Low
1.850
Dividend TTM
--
Div Yield TTM
--
P/B
3.62
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.99%
Amplitude
2.49%
Avg Price
66.558
Lot Size
1
Float Cap
12.20B
Bid/Ask %
0.00%
Historical High
153.150
Shs Float
183.64M
Volume Ratio
1.47
Historical Low
1.850
Dividend TTM
--
P/B
3.62
Dividend LFY
--
Turnover Ratio
0.99%
Amplitude
2.49%
Avg Price
66.558
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.
CEO: Mr. Herve Hoppenot
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...